Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09553 | 31696128 | Hypoxia (Auckl) | Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas. | 2019 | Details |
| A09554 | 31695954 | Food Sci Biotechnol | Dansameum regulates hepatic lipogenesis and inflammation in vitro and in vivo. | 2019 | Details |
| A09555 | 31695254 | J Clin Exp Hepatol | A Novel Phosphoinositide-3-kinase Adapter Protein 1 Gene Missense Mutation in Familial Cirrhosis. | 2019 | Details |
| A09556 | 31695252 | J Clin Exp Hepatol | Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation. | 2019 | Details |
| A09557 | 31695251 | J Clin Exp Hepatol | Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A09558 | 31695245 | J Clin Exp Hepatol | Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09559 | 31695090 | Sci Rep | Transcriptomic Analysis of mRNA-lncRNA-miRNA Interactions in Hepatocellular Carcinoma. | 2019 | Details |
| A09560 | 31694366 | Korean J Intern Med | Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study. | 2019 | Details |
| A09561 | 31694365 | Gut Liver | Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A09562 | 31694082 | Diabetes Metab J | Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms. | 2019 | Details |
| A09563 | 31693842 | Ultrasonography | Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. | 2019 | Details |
| A09565 | 31693695 | PLoS One | The impact of hepatic steatosis on portal hypertension. | 2019 | Details |
| A09566 | 31692556 | Diabetes Metab Syndr Obes | Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice. | 2019 | Details |
| A09567 | 31692530 | Pediatric Health Med Ther | Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management. | 2019 | Details |
| A09568 | 31692390 | Expert Rev Gastroenterol Hepatol | Progress in promising anti-fibrotic therapies. | 2019 | Details |
| A09569 | 31692226 | Diabetes Obes Metab | Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes. | 2019 | Details |
| A09570 | 31692179 | Hepatol Res | Creatinine-to-bodyweight ratio is a predictor of incident non-alcoholic fatty liver disease: A population-based longitudinal study. | 2019 | Details |
| A09571 | 31691993 | J Med Virol | The impact of hepatitis B virus infection status on the prevalence of nonalcoholic fatty liver disease: A population-based study. | 2019 | Details |
| A09572 | 31691175 | Curr Obes Rep | Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. | 2019 | Details |
| A09573 | 31690988 | Diabetologia | Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation. | 2019 | Details |
| A09574 | 31690932 | J Clin Endocrinol Metab | Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. | 2020 | Details |
| A09575 | 31689910 | Nutrients | The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. | 2019 | Details |
| A09576 | 31689883 | Foods | Agaricus brasiliensis KA21 May Prevent Diet-Induced Nash Through Its Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Activities in the Liver. | 2019 | Details |
| A09577 | 31689846 | Medicine (Baltimore) | Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis. | 2019 | Details |
| A09578 | 31689560 | Cell Mol Gastroenterol Hepatol | A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. | 2019 | Details |
| A09579 | 31689496 | Diabetes Metab | Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. | 2019 | Details |
| A09580 | 31688897 | QJM | Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea. | 2020 | Details |
| A09581 | 31688305 | Eur J Gastroenterol Hepatol | Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A09582 | 31687367 | Can J Gastroenterol Hepatol | The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. | 2019 | Details |
| A09583 | 31686884 | Diabetes Metab Syndr Obes | Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide. | 2019 | Details |
| A09584 | 31686762 | World J Gastroenterol | Ultrasound-based techniques for the diagnosis of liver steatosis. | 2019 | Details |
| A09585 | 31686320 | Sci China Life Sci | Regulation of glucose and lipid metabolism in health and disease. | 2019 | Details |
| A09586 | 31686136 | Cardiovasc Intervent Radiol | Transarterial Chemoembolization of Hepatocellular Carcinoma: Propensity Score Matching Study Comparing Survival and Complications in Patients with Nonalcoholic Steatohepatitis Versus Other Causes Cirrhosis. | 2019 | Details |
| A09587 | 31685793 | Nutr Diabetes | Energy restriction in obese women suggest linear reduction of hepatic fat content and time-dependent metabolic improvements. | 2019 | Details |
| A09588 | 31685037 | Br J Nutr | Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. | 2019 | Details |
| A09589 | 31684925 | BMC Complement Altern Med | The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet. | 2019 | Details |
| A09590 | 31683679 | Molecules | Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats. | 2019 | Details |
| A09591 | 31682643 | Frontline Gastroenterol | A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health. | 2019 | Details |
| A09593 | 31682638 | PLoS One | Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population. | 2019 | Details |
| A09594 | 31682518 | Endocr Pract | CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. | 2019 | Details |
| A09595 | 31682409 | Environ Sci Technol | Inhibition of Mitochondrial Fatty Acid Oxidation Contributes to Development of Nonalcoholic Fatty Liver Disease Induced by Environmental Cadmium Exposure. | 2019 | Details |
| A09596 | 31682309 | J Dig Dis | Development of new drugs for the treatment of nonalcoholic steatohepatitis. | 2019 | Details |
| A09597 | 31680967 | Front Pharmacol | Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms. | 2019 | Details |
| A09600 | 31679693 | Biochem Biophys Res Commun | Identification of isotschimgine as a novel farnesoid X receptor agonist with potency for the treatment of obesity in mice. | 2019 | Details |
| A09601 | 31679316 | Clin Mol Hepatol | Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. | 2019 | Details |
| A09602 | 31678261 | Food Chem Toxicol | Cigarette smoking differentially regulates inflammatory responses in a mouse model of nonalcoholic steatohepatitis depending on exposure time point. | 2019 | Details |
| A09603 | 31678070 | Metabolism | Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. | 2019 | Details |
| A09604 | 31677889 | Nutr Metab Cardiovasc Dis | Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD. | 2019 | Details |
| A09605 | 31677710 | Clin Nutr ESPEN | The relationship between dietary antioxidant intake and physical activity rate with nonalcoholic fatty liver disease (NAFLD): A case - Control study. | 2019 | Details |
| A09608 | 31677195 | J Gastroenterol Hepatol | Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. | 2019 | Details |
| A09609 | 31676775 | Sci Rep | Characterizing the Role of HMG-CoA Reductase in Aryl Hydrocarbon Receptor-Mediated Liver Injury in C57BL/6 Mice. | 2019 | Details |
| A09610 | 31676768 | Exp Mol Med | Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases. | 2019 | Details |
| A09611 | 31675427 | Hepatology | Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A09612 | 31675274 | Metab Syndr Relat Disord | Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection. | 2019 | Details |
| A09613 | 31674780 | J Agric Food Chem | γ-Mangostin Ameliorates Free Fatty Acid-Induced Lipid Accumulation via the SIRT1/LKB1/AMPK Pathway in HepG2 and L02 Cells. | 2019 | Details |
| A09614 | 31673703 | Endocrinology | Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression. | 2020 | Details |
| A09618 | 31673534 | Hepatobiliary Surg Nutr | Endogenously increased n-3 PUFA levels in fat-1 transgenic mice do not protect from non-alcoholic steatohepatitis. | 2019 | Details |
| A09619 | 31672578 | Life Sci | Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. | 2019 | Details |
| A09620 | 31672448 | Metabolism | Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box! | 2019 | Details |
| A09621 | 31672443 | Metabolism | Fibroblast growth factor 21 in non-alcoholic fatty liver disease. | 2019 | Details |
| A09622 | 31671785 | Nutrients | mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. | 2019 | Details |
| A09623 | 31671697 | Cells | Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression. | 2019 | Details |
| A09624 | 31671589 | Nutrients | Effects of Periodic Fasting on Fatty Liver Index-A Prospective Observational Study. | 2019 | Details |
| A09625 | 31670498 | Panminerva Med | Liver disease and heart failure. | 2019 | Details |
| A09626 | 31670489 | ChemMedChem | Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast. | 2019 | Details |
| A09627 | 31670060 | Pharmacol Rep | Hepatoprotective potential of 7,8-Dihydroxyflavone against alcohol and high-fat diet induced liver toxicity via attenuation of oxido-nitrosative stress and NF-κB activation. | 2019 | Details |
| A09628 | 31669275 | Int J Biol Macromol | Codonopsis lanceolata polysaccharide CLPS alleviates high fat/high sucrose diet-induced insulin resistance via anti-oxidative stress. | 2019 | Details |
| A09629 | 31668954 | Environ Pollut | Prenatal exposure to diesel exhaust PM2.5 programmed non-alcoholic fatty liver disease differently in adult male offspring of mice fed normal chow and a high-fat diet. | 2019 | Details |
| A09630 | 31668939 | J Ren Nutr | The Separate Contributions of Visceral Fat and Liver Fat to Chronic Kidney Disease-Related Renal Outcomes. | 2019 | Details |
| A09631 | 31668723 | Clin Nutr | Dietary n-6 to n-3 fatty acid ratio is related to liver fat content independent of genetic effects: Evidence from the monozygotic co-twin control design. | 2019 | Details |
| A09632 | 31668396 | Mol Metab | PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease. | 2019 | Details |
| A09633 | 31668391 | Mol Metab | miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease. | 2019 | Details |
| A09634 | 31668386 | Mol Metab | Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. | 2019 | Details |
| A09635 | 31668088 | Int J Environ Health Res | Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model. | 2019 | Details |
| A09638 | 31665722 | Cardiology | Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study. | 2019 | Details |
| A09639 | 31665561 | Liver Transpl | Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. | 2020 | Details |
| A09640 | 31662869 | United European Gastroenterol J | Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram. | 2019 | Details |
| A09641 | 31662868 | United European Gastroenterol J | Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. | 2019 | Details |
| A09642 | 31661783 | Metabolites | A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice. | 2019 | Details |
| A09643 | 31661724 | Hepatol Res | Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis. | 2019 | Details |
| A09644 | 31661720 | Hepatol Res | Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice. | 2020 | Details |
| A09645 | 31661524 | PLoS One | Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study. | 2019 | Details |
| A09646 | 31660146 | Food Sci Nutr | Fermented black radish (Raphanus sativus L. var. niger) attenuates methionine and choline deficient diet-induced nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A09648 | 31659239 | Acta Pharmacol Sin | Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. | 2019 | Details |
| A09649 | 31659105 | Cancer Genomics Proteomics | Synergism of Adipocytokine Profile and ADIPOQ/TNF-α Polymorphisms in NAFLD-associated MetS Predict Colorectal Liver Metastases Outgrowth. | 2020 | Details |
| A09650 | 31658974 | Diabetes Care | Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S. | 2019 | Details |
| A09651 | 31658321 | Rom J Morphol Embryol | Thymoquinone reverses nonalcoholic fatty liver disease (NAFLD) associated with experimental hypothyroidism. | 2019 | Details |
| A09652 | 31657614 | J Altern Complement Med | Electroacupuncture Versus Aerobic Interval Training on Liver Functions in Patients with Nonalcoholic Fatty Liver. | 2019 | Details |
| A09653 | 31657510 | Mol Nutr Food Res | The Buckwheat Iminosugar d-Fagomine Attenuates Sucrose-Induced Steatosis and Hypertension in Rats. | 2019 | Details |
| A09656 | 31657148 | Obesity (Silver Spring) | Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09657 | 31657145 | Pediatr Obes | Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease. | 2019 | Details |
| A09658 | 31656991 | Rev Endocr Metab Disord | Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease. | 2019 | Details |
| A09659 | 31656291 | J Med Invest | The Effect of Laparoscopic Sleeve Gastrectomy on Obesity and Obesity-related Disease : the Results of 10 Initial Cases. | 2019 | Details |
| A09660 | 31656024 | Hormones (Athens) | Potential clinical variants detected in mitochondrial DNA D-loop hypervariable region I of patients with non-alcoholic steatohepatitis. | 2019 | Details |
| A09661 | 31655133 | J Hepatol | β-Klotho gene variation is associated with liver damage in children with NAFLD. | 2019 | Details |
| A09662 | 31654717 | Cell Signal | Identification of Nogo-B as a new molecular target of peroxisome proliferator-activated receptor gamma. | 2019 | Details |
| A09663 | 31654131 | J Gastroenterol | Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study. | 2019 | Details |
| A09666 | 31653116 | Int J Mol Sci | The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota. | 2019 | Details |
| A09667 | 31652839 | Int J Mol Sci | The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications. | 2019 | Details |
| A09668 | 31652837 | Cancers (Basel) | Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer. | 2019 | Details |